H van Dekken
Overview
Explore the profile of H van Dekken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
3494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Hagen P, Hulshof M, van Lanschot J, Steyerberg E, van Berge Henegouwen M, Wijnhoven B, et al.
N Engl J Med
. 2012 Jun;
366(22):2074-84.
PMID: 22646630
Background: The role of neoadjuvant chemoradiotherapy in the treatment of patients with esophageal or esophagogastric-junction cancer is not well established. We compared chemoradiotherapy followed by surgery with surgery alone in...
2.
Van der Zee J, van Eijck C, Hop W, van Dekken H, Dicheva B, Seynhaeve A, et al.
Eur J Surg Oncol
. 2012 May;
38(11):1058-64.
PMID: 22633450
Background: Pancreatic cancer has a dismal prognosis. Attempts have been made to improve outcome by several 5-FU based adjuvant treatment regimens. However, the results are conflicting. There seems to be...
3.
Lagerveld B, van Dekken H, van Leenders G, Van der Zee J
Adv Urol
. 2012 Apr;
2012:539648.
PMID: 22518116
Objective. We evaluated histological outcome of intraoperative biopsies at laparoscopic renal mass cryoablation (LCA), prevalence of peritumoral fat tissue invasion, and risk of tract seeding. Methods. Patients were biopsied 3-5...
4.
Selder J, van Dekken H, de Voogt W
Neth Heart J
. 2011 Nov;
23(1):74-6.
PMID: 22113594
No abstract available.
5.
Sikkema M, Looman C, Steyerberg E, Kerkhof M, Kastelein F, van Dekken H, et al.
Am J Gastroenterol
. 2011 May;
106(7):1231-8.
PMID: 21577245
Objectives: Patients with Barrett's esophagus (BE) have an increased risk of developing esophageal adenocarcinoma (EAC). As the absolute risk remains low, there is a need for predictors of neoplastic progression...
6.
den Hoed C, de Vries A, Mensink P, Dierikx C, Suzuki H, Capelle L, et al.
Can J Gastroenterol
. 2011 Apr;
25(4):207-13.
PMID: 21523262
Background: Antibiotic-based regimens are frequently used for the treatment of Helicobacter pylori infection. These regimens fail to eradicate H pylori in 15% to 40% of patients, primarily due to antimicrobial...
7.
den Hoed C, van Eijck B, Capelle L, van Dekken H, Biermann K, Siersema P, et al.
Eur J Cancer
. 2011 Jan;
47(8):1211-8.
PMID: 21239166
Background: Helicobacter pylori is the main risk-factor for gastric cancer through a cascade from gastritis through atrophic gastritis (AG), intestinal metaplasia (IM), dysplasia (DYS) to malignancy. The presence of these...
8.
Leeuwenburgh I, Gerrits M, Capello A, van den Bogert B, van Dekken H, Steyerberg E, et al.
Dis Esophagus
. 2010 Feb;
23(6):506-11.
PMID: 20113324
Patients with longstanding achalasia have an increased risk of developing esophageal cancer. Surveillance is hampered by chronic stasis. We investigated whether aberrant expressions of tumor suppressor gene p53 and proliferation...
9.
Hol L, van Leerdam M, van Ballegooijen M, van Vuuren A, van Dekken H, Reijerink J, et al.
Gut
. 2009 Aug;
59(1):62-8.
PMID: 19671542
Background: Screening for colorectal cancer (CRC) is widely accepted, but there is no consensus on the preferred strategy. We conducted a randomised trial comparing participation and detection rates (DR) per...
10.
Boonstra J, Koppert L, Wijnhoven B, Tilanus H, van Dekken H, Tran T, et al.
J Surg Oncol
. 2009 Aug;
100(5):407-13.
PMID: 19653239
Background: Patients with carcinoma of the distal esophagus and metastatic celiac lymph nodes (M1a) have a poor prognosis and are often denied surgery. In this study, we evaluated our treatment...